A phenomenological analysis of the subjective experience elicited by ibogaine in the context of a drug dependence treatment Read More > August 29, 2017
Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic Read More > August 26, 2017
Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons Read More > August 23, 2017
Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs Read More > August 18, 2017
Horizontal gene cluster transfer increased hallucinogenic mushroom diversity Read More > August 16, 2017
The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish Read More > August 14, 2017
MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent ‘Ecstasy’ users Read More > August 8, 2017
Shannon entropy of brain functional complex networks under the influence of the psychedelic Ayahuasca Read More > August 7, 2017
